X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4623) 4623
Book Chapter (18) 18
Magazine Article (11) 11
Book / eBook (6) 6
Newspaper Article (4) 4
Reference (3) 3
Conference Proceeding (2) 2
Web Resource (2) 2
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4172) 4172
male (2564) 2564
female (2409) 2409
science & technology (2230) 2230
iodine radioisotopes - therapeutic use (2204) 2204
life sciences & biomedicine (2189) 2189
iodine radioisotopes - adverse effects (2067) 2067
middle aged (1955) 1955
adult (1763) 1763
aged (1513) 1513
iodine radioisotopes (1062) 1062
thyroid neoplasms - radiotherapy (717) 717
abridged index medicus (677) 677
animals (645) 645
treatment outcome (640) 640
oncology (639) 639
radiology, nuclear medicine & medical imaging (623) 623
adolescent (581) 581
brachytherapy - adverse effects (546) 546
follow-up studies (538) 538
radiotherapy dosage (494) 494
aged, 80 and over (480) 480
endocrinology & metabolism (480) 480
retrospective studies (476) 476
child (462) 462
iodine radioisotopes - administration & dosage (440) 440
thyroid cancer (437) 437
radionuclide imaging (425) 425
time factors (420) 420
prostatic neoplasms - radiotherapy (411) 411
brachytherapy - methods (365) 365
risk factors (363) 363
care and treatment (362) 362
thyroidectomy (360) 360
iodine (346) 346
brachytherapy (344) 344
cancer (332) 332
hyperthyroidism - radiotherapy (310) 310
thyroid neoplasms - pathology (309) 309
radiotherapy (299) 299
combined modality therapy (292) 292
radiation dosage (290) 290
graves disease - radiotherapy (282) 282
thyroid neoplasms - surgery (262) 262
patients (261) 261
hypothyroidism - etiology (255) 255
radiation injuries - etiology (252) 252
medicine & public health (242) 242
dose-response relationship, radiation (241) 241
radiopharmaceuticals - therapeutic use (239) 239
nuclear medicine (237) 237
thyroid (232) 232
pregnancy (231) 231
rats (226) 226
surgery (226) 226
radiotherapy - adverse effects (217) 217
thyroid gland - radiation effects (216) 216
child, preschool (213) 213
thyroid neoplasms - etiology (209) 209
isotopes (208) 208
iodine radioisotopes - pharmacokinetics (204) 204
health aspects (200) 200
young adult (198) 198
prognosis (197) 197
prospective studies (197) 197
radiology (194) 194
radioisotopes (193) 193
radiopharmaceuticals - adverse effects (192) 192
prostate cancer (187) 187
neoplasms, radiation-induced - etiology (186) 186
antithyroid agents - therapeutic use (181) 181
mice (174) 174
thyroid gland (174) 174
research (173) 173
hyperthyroidism (168) 168
medicine (162) 162
thyrotropin - blood (162) 162
iodine isotopes (157) 157
thyroid neoplasms - drug therapy (157) 157
neoplasm staging (154) 154
general & internal medicine (153) 153
radioisotope brachytherapy (151) 151
medicine, general & internal (149) 149
thyroid neoplasms - therapy (147) 147
thyroid neoplasms - diagnostic imaging (144) 144
analysis (143) 143
radiology and nuclear medicine (141) 141
antibodies, monoclonal - therapeutic use (140) 140
thyroid function tests (139) 139
tomography, x-ray computed (139) 139
hematology, oncology and palliative medicine (136) 136
prostatic neoplasms - pathology (136) 136
disease-free survival (134) 134
thyroxine - blood (133) 133
radioiodine (131) 131
infant (130) 130
radiation therapy (130) 130
thyroid diseases (129) 129
tumors (129) 129
hypothyroidism (128) 128
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4149) 4149
German (161) 161
French (110) 110
Russian (83) 83
Japanese (81) 81
Spanish (49) 49
Chinese (33) 33
Polish (27) 27
Portuguese (27) 27
Italian (25) 25
Czech (12) 12
Dutch (11) 11
Swedish (11) 11
Hungarian (9) 9
Danish (8) 8
Ukrainian (7) 7
Turkish (4) 4
Norwegian (3) 3
Croatian (2) 2
Finnish (2) 2
Hebrew (2) 2
Romanian (2) 2
Serbian (2) 2
Bulgarian (1) 1
Korean (1) 1
Lithuanian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2010, Volume 77, Issue 5, pp. 1338 - 1344
Purpose To describe long-term outcomes and toxicity after salvage brachytherapy (BT) for local failure after initial radiotherapy for prostate cancer. Methods... 
Radiology | Hematology, Oncology and Palliative Medicine | Prostate cancer | Brachytherapy | Salvage therapy | Oncology | Life Sciences & Biomedicine | Radiology, Nuclear Medicine & Medical Imaging | Science & Technology | Radiotherapy Dosage | Salvage Therapy - adverse effects | Prostatic Neoplasms - radiotherapy | Lymph Node Excision - adverse effects | Follow-Up Studies | Prostatic Neoplasms - surgery | Urination Disorders - therapy | Humans | Middle Aged | Radioisotopes - adverse effects | Brachytherapy - methods | Male | Treatment Outcome | Erectile Dysfunction - etiology | Pelvis | Prostate-Specific Antigen - blood | Iodine Radioisotopes - adverse effects | Palladium - adverse effects | Analysis of Variance | Urination Disorders - etiology | Prostatic Neoplasms - blood | Aged | Brachytherapy - adverse effects | Salvage Therapy - methods | Radioisotope brachytherapy | Index Medicus | Age | INTERMEDIATE MASS NUCLEI | FAILURES | MALE GENITALS | MEDICINE | IODINE 125 | PALLADIUM 103 | INTERNAL CONVERSION RADIOISOTOPES | THERAPY | GLANDS | BETA DECAY RADIOISOTOPES | RADIOLOGY AND NUCLEAR MEDICINE | RADIOTHERAPY | RADIOLOGY | PROSTATE | PALLADIUM ISOTOPES | NEOPLASMS | RADIOISOTOPES | TOXICITY | NUCLEAR MEDICINE | ODD-EVEN NUCLEI | ELECTRON CAPTURE RADIOISOTOPES | ISOTOPES | ORGANS | IODINE ISOTOPES | DISEASES | NUCLEI | DAYS LIVING RADIOISOTOPES | EVEN-ODD NUCLEI | BRACHYTHERAPY | BODY
Journal Article
Journal Article
The Lancet (British edition), ISSN 0140-6736, 08/2016, Volume 388, Issue 10047, pp. 906 - 918
Summary Hyperthyroidism is characterised by increased thyroid hormone synthesis and secretion from the thyroid gland, whereas thyrotoxicosis refers to the... 
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Graves Disease - diagnosis | Hyperthyroidism - diagnosis | Humans | Thyroid Crisis - therapy | Patient Care Team | Thyrotoxicosis - metabolism | Hyperthyroidism - metabolism | Thyrotoxicosis - drug therapy | Amiodarone - administration & dosage | Iodine Radioisotopes - adverse effects | Amiodarone - adverse effects | Iodine Radioisotopes - therapeutic use | Thyroid Hormones - blood | Female | Pregnancy Complications - metabolism | Hyperthyroidism - epidemiology | Adrenergic beta-Antagonists - therapeutic use | Graves Disease - metabolism | Antithyroid Agents - adverse effects | Diagnosis, Differential | Thyroid Hormones - biosynthesis | Drug Administration Schedule | Risk Factors | Antithyroid Agents - therapeutic use | Hyperthyroidism - therapy | Pregnancy Complications - diagnosis | Antithyroid Agents - administration & dosage | Graves Disease - therapy | Thyroidectomy - adverse effects | Thyrotoxicosis - diagnosis | Pregnancy | Iodine Radioisotopes - administration & dosage | Thyroid Crisis - diagnosis | Thyroid Gland - metabolism | Practice Guidelines as Topic | Pregnancy Complications - therapy | Medical colleges | Thyroid gland | Thyroid hormones | Radiotherapy | Adrenergic beta blockers | Hyperthyroidism | Hormones | Health risk assessment | Drug dosages | Iodine | Index Medicus | Abridged Index Medicus
Journal Article
Thyroid (New York, N.Y.), ISSN 1050-7256, 09/2017, Volume 27, Issue 9, pp. 1135 - 1141
Background: While there is a clear consensus for defining radioiodine-refractory differentiated thyroid cancer (RR-DTC), it is unknown whether these criteria... 
Phase 3 | radioiodine therapy | thyroid cancer | multitargeted kinase inhibitor | lenvatinib | Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Follow-Up Studies | Tumor Burden - radiation effects | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Protein Kinase Inhibitors - adverse effects | Iodine Radioisotopes - adverse effects | Tissue Distribution | Iodine Radioisotopes - therapeutic use | Antineoplastic Agents - adverse effects | Phenylurea Compounds - adverse effects | Treatment Failure | Aged, 80 and over | Adult | Female | Radiopharmaceuticals - pharmacokinetics | Thyroid Neoplasms - mortality | Double-Blind Method | Phenylurea Compounds - therapeutic use | Terminology as Topic | Thyroid Neoplasms - radiotherapy | Iodine Radioisotopes - pharmacokinetics | Cross-Over Studies | Radiopharmaceuticals - administration & dosage | Iodine Radioisotopes - administration & dosage | Thyroid Neoplasms - drug therapy | Tumor Burden - drug effects | Protein Kinase Inhibitors - therapeutic use | Survival Analysis | Aged | Quinolines - therapeutic use | Radiopharmaceuticals - adverse effects | Dose-Response Relationship, Radiation | Quinolines - adverse effects | Radiopharmaceuticals - therapeutic use | Thyroid Neoplasms - pathology | Index Medicus | Thyroid Cancer and Nodules
Journal Article
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2011, Volume 80, Issue 5, pp. 1323 - 1329
Purpose To report outcomes for 1,111 men treated with iodine-125 brachytherapy (BT) at a single institution. Methods and Materials A total of 1,111 men (median... 
Radiology | Hematology, Oncology and Palliative Medicine | Prostate neoplasms | Brachytherapy | Radiotherapy | Prostate-specific antigen | Prostatic Neoplasms - radiotherapy | Adenocarcinoma - pathology | Prospective Studies | Humans | Middle Aged | Male | Iodine Radioisotopes - therapeutic use | Aged, 80 and over | Prostatic Neoplasms - blood | Adenocarcinoma - radiotherapy | Radiotherapy Dosage | Prostatic Neoplasms - pathology | Adenocarcinoma - blood | Brachytherapy - methods | Proportional Hazards Models | Urination Disorders - drug therapy | Prostate-Specific Antigen - blood | Prostatic Neoplasms - mortality | Disease-Free Survival | Neoadjuvant Therapy - methods | Aged | Penile Erection - physiology | Neoplasm Staging | Ontario | Prostate | Brachytherapy - adverse effects | Adenocarcinoma - mortality | Radioisotope brachytherapy | Hospitals | Ants | Index Medicus | INTERMEDIATE MASS NUCLEI | BIOPSY | MALE GENITALS | ANTIGENS | MEDICINE | IODINE 125 | INTERNAL CONVERSION RADIOISOTOPES | MATHEMATICS | MULTIVARIATE ANALYSIS | THERAPY | GLANDS | BETA DECAY RADIOISOTOPES | RADIOLOGY AND NUCLEAR MEDICINE | RADIOTHERAPY | RADIOLOGY | PROSTATE | DIAGNOSTIC TECHNIQUES | NEOPLASMS | STATISTICS | RADIOISOTOPES | NUCLEAR MEDICINE | ODD-EVEN NUCLEI | ELECTRON CAPTURE RADIOISOTOPES | ISOTOPES | ORGANS | IODINE ISOTOPES | DISEASES | NUCLEI | DAYS LIVING RADIOISOTOPES | BRACHYTHERAPY | BODY | HAZARDS | HORMONES
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 11/2011, Volume 103, Issue 21, pp. 1572 - 1587
..., interleukin-2, ipilimumab, tremelimumab, thalidomide, and lenalidomide. Primary hypothyroidism is the most common side effect, although thyrotoxicosis and effects on thyroid... 
Life Sciences & Biomedicine | Oncology | Science & Technology | Hypothyroidism - chemically induced | Thyroid Function Tests | Hyperthyroidism - diagnosis | Interleukin-2 - adverse effects | Recombinant Fusion Proteins - adverse effects | Humans | Ipilimumab | Antibodies, Monoclonal - adverse effects | Antineoplastic Agents - administration & dosage | Recombinant Proteins - adverse effects | Tetrahydronaphthalenes - adverse effects | Hyperthyroidism - chemically induced | Thalidomide - analogs & derivatives | Antineoplastic Agents - adverse effects | Diphtheria Toxin - adverse effects | Thyroid Hormones - blood | Anticarcinogenic Agents - adverse effects | Interleukin-2 - analogs & derivatives | Thyroiditis, Autoimmune - chemically induced | Molecular Targeted Therapy - methods | Thyroid Gland - drug effects | Thalidomide - adverse effects | Antibodies, Monoclonal, Humanized - adverse effects | Hyperthyroidism - blood | Radioimmunotherapy | Hypopituitarism - etiology | Hypothyroidism - diagnosis | Alemtuzumab | Hypothyroidism - etiology | Neoplasms - drug therapy | Iodine Radioisotopes - administration & dosage | Hypopituitarism - complications | Neoplasms - immunology | Hypothyroidism - drug therapy | Quality of Life | Interferon-alpha - adverse effects | Hypothyroidism - blood | Thyroid Gland - metabolism | Antibodies, Neoplasm - adverse effects | Protein-Tyrosine Kinases - antagonists & inhibitors | Antimitotic agents | Complications and side effects | Usage | Thyroid diseases | Diagnosis | Antineoplastic agents | Thyroid gland function tests | Risk factors | Hypothyroidism | Medical diagnosis | Medical treatment | Index Medicus | Review
Journal Article